Tech Company Financing Transactions
iFAST Diagnostics Funding Round
iFAST Diagnostics, based in Whiteley, Fareham, raised $6.7 million from Cambridge Capital, Innovate UK and OKG Capital.
Transaction Overview
Company Name
Announced On
5/27/2026
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$6,700,000
Round
Undisclosed
Proceeds Purpose
The funding will be used to expand the UK rollout, secure EU approval, and accelerate our clinical and regulatory programme for the company's US regulatory approval through the FDA.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Solent Business Park, 1500 Parkway
Whiteley, Fareham, PO15 7AF
UK
Whiteley, Fareham, PO15 7AF
UK
Phone
Undisclosed
Website
Email Address
Overview
iFAST Diagnostics is a UK-based biotechnology company developing an ultra-rapid antimicrobial susceptibility test (AST) system designed to identify optimal antibiotic treatments in under three hours.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Toby King
Chief Technical Officer
Hywel Morgan
VP - Engineering
Dan Spencer
Browse more venture capital transactions:
Prev: 5/27/2026: Canyon Code venture capital transaction
Next: 5/27/2026: Patron Points venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on funding rounds that are announced publicly. All VC database entries reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs